190 related articles for article (PubMed ID: 26846845)
1. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.
Pagani E; Ruffini F; Antonini Cappellini GC; Scoppola A; Fortes C; Marchetti P; Graziani G; D'Atri S; Lacal PM
Int J Oncol; 2016 Apr; 48(4):1581-9. PubMed ID: 26846845
[TBL] [Abstract][Full Text] [Related]
2. Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin.
Ruffini F; Graziani G; Levati L; Tentori L; D'Atri S; Lacal PM
Int J Cancer; 2015 Mar; 136(6):E545-58. PubMed ID: 25284767
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms.
Ruffini F; D'Atri S; Lacal PM
Int J Oncol; 2013 Jul; 43(1):297-306. PubMed ID: 23685409
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.
Ruffini F; Levati L; Graziani G; Caporali S; Atzori MG; D'Atri S; Lacal PM
Oncotarget; 2017 Sep; 8(40):66833-66848. PubMed ID: 28977999
[TBL] [Abstract][Full Text] [Related]
5. Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib.
Atzori MG; Ceci C; Ruffini F; Trapani M; Barbaccia ML; Tentori L; D'Atri S; Lacal PM; Graziani G
J Cell Mol Med; 2020 Jan; 24(1):465-475. PubMed ID: 31758648
[TBL] [Abstract][Full Text] [Related]
6. Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB.
Levati L; Ruffini F; Muzi A; Umezawa K; Graziani G; D'Atri S; Lacal PM
Int J Oncol; 2011 Jan; 38(1):241-7. PubMed ID: 21109946
[TBL] [Abstract][Full Text] [Related]
7. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
Lacal PM; Ruffini F; Pagani E; D'Atri S
Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219
[TBL] [Abstract][Full Text] [Related]
8. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
[TBL] [Abstract][Full Text] [Related]
12. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
[TBL] [Abstract][Full Text] [Related]
13. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
BMC Cancer; 2015 Mar; 15():104. PubMed ID: 25880726
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas.
Schneider K; Weyerbrock A; Doostkam S; Plate K; Machein MR
J Neurooncol; 2015 Jan; 121(2):269-78. PubMed ID: 25370707
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract][Full Text] [Related]
17. Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition.
Pérez-Lozano ML; Sandoval P; Rynne-Vidal A; Aguilera A; Jiménez-Heffernan JA; Albar-Vizcaíno P; Majano PL; Sánchez-Tomero JA; Selgas R; López-Cabrera M
PLoS One; 2013; 8(4):e60776. PubMed ID: 23585849
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
19. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells.
Ohsaka A; Hirota-Komatsu S; Shibata M; Komatsu N
Biochem Biophys Res Commun; 2009 Dec; 390(4):1171-6. PubMed ID: 19857463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
